Granules India has acquired Swiss CDMO company Senn Chemicals AG for Rs 192 crore, expanding its peptide therapeutics market ...

In a bid to break into the CDMO business at one of its most lucrative angles, India's Granules is snapping up Swiss contract ...

Granules India advanced 1.95% to Rs 519 after the company said that its board has approved to acquire 100% stake in Senn Chemicals AG, a Switzerland based company, for a total consideration of Rs 192.

Generic drugmaker Granules India is foraying into the peptide segment and contract development and manufacturing organisation ...

Granules India enters peptide segment and CDMO business by acquiring Senn Chemicals AG: Our Bureau, Bengaluru Monday, February 24, 2025, 12:20 Hrs [IST] Granules India, a generic ...

With this acquisition, Granules gains capabilities in high-growth peptide-based therapeutics. It also aims to enter the ...

Zydus Lifesciences: The company and its subsidiaries received final approval from the United States Food and Drug Administration (US FDA) to manufacture Ibuprofen and Famotidine tablets, 800 mg/26.6 ...

Granules India acquires Senn Chemicals AG, expanding into peptide therapeutics and CDMO capabilities for global growth.

Granules India has purchased Senn Chemicals AG, a Swiss CDMO firm specializing in peptide therapeutics, for CHF 20 million.

Generic drugmaker Granules India is foraying into the peptide segment and contract development and manufacturing organisation (CDMO) business with a ₹192.5 crore (CHF 20 million) acquisition of ...